Application no. and date | 19779145.2 (espacenet) (Federated) (European Patent Register), 20190812 | Patent/reg. no. and date | DK/EP 3837256, 20230308 | Publication date | 20210623 | Priority no. and date | US 201862765138 P, 20180817 | EP pub. no. and date |
EP 3837256 20210623 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | 168150/BT/GP | Inventor | ADAIR, Christopher, 157 Murdock Street, Unit 3
Brighton, Massachusetts 02135, US, PAPILLON, Julien, Novartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US, NAKAJIMA, Katsumasa, Novartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US, SMITH, Troy Douglas, Novartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US, NTAGANDA, Rukundo, Novartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4439 (2006.01) , A61P 35/00 (2006.01) , C07D 417/12 (2006.01) | Title | UREAFORBINDELSER OG SAMMENSÆTNINGER SOM SMARCA2/BRM-ATPASE-HÆMMERE | Int. application no. | IB2019056847 | Int. publication no. | WO2020035779 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|